KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $758 | -43.8% | 873,274 | -2.2% | 0.00% | – |
Q1 2024 | $1,348 | +60.9% | 892,815 | -8.0% | 0.00% | – |
Q4 2023 | $838 | -45.7% | 970,062 | -15.8% | 0.00% | -100.0% |
Q3 2023 | $1,544 | -22.1% | 1,152,298 | +4.2% | 0.00% | 0.0% |
Q2 2023 | $1,982 | -82.1% | 1,106,361 | -61.1% | 0.00% | -80.0% |
Q1 2023 | $11,077 | +211.3% | 2,847,389 | +172.0% | 0.01% | +150.0% |
Q4 2022 | $3,558 | -99.9% | 1,046,712 | +129.8% | 0.00% | -33.3% |
Q3 2022 | $2,487,000 | +574.0% | 455,464 | +456.0% | 0.00% | – |
Q2 2022 | $369,000 | -42.9% | 81,925 | -6.6% | 0.00% | -100.0% |
Q1 2022 | $646,000 | -72.4% | 87,724 | -75.9% | 0.00% | – |
Q4 2021 | $2,338,000 | +203.6% | 363,504 | +174.6% | 0.00% | – |
Q3 2021 | $770,000 | -62.5% | 132,389 | -33.4% | 0.00% | -100.0% |
Q2 2021 | $2,052,000 | -28.9% | 198,775 | -27.6% | 0.00% | -50.0% |
Q1 2021 | $2,887,000 | -19.1% | 274,374 | +19.1% | 0.00% | 0.0% |
Q4 2020 | $3,569,000 | +357.0% | 230,465 | +330.8% | 0.00% | – |
Q3 2020 | $781,000 | -42.7% | 53,492 | -25.7% | 0.00% | -100.0% |
Q2 2020 | $1,364,000 | +18.5% | 72,015 | +20.2% | 0.00% | 0.0% |
Q1 2020 | $1,151,000 | -31.2% | 59,937 | -31.4% | 0.00% | 0.0% |
Q4 2019 | $1,674,000 | +399.7% | 87,347 | +151.0% | 0.00% | – |
Q3 2019 | $335,000 | +24.1% | 34,802 | -22.9% | 0.00% | – |
Q2 2019 | $270,000 | +110.9% | 45,153 | +105.4% | 0.00% | – |
Q1 2019 | $128,000 | +39.1% | 21,985 | +122.9% | 0.00% | – |
Q4 2018 | $92,000 | -91.7% | 9,864 | -84.8% | 0.00% | -100.0% |
Q3 2018 | $1,105,000 | +140.7% | 64,887 | +139.9% | 0.00% | – |
Q2 2018 | $459,000 | -20.5% | 27,045 | -37.1% | 0.00% | – |
Q1 2018 | $577,000 | +111.4% | 42,985 | +50.7% | 0.00% | – |
Q4 2017 | $273,000 | +245.6% | 28,526 | +298.6% | 0.00% | – |
Q3 2017 | $79,000 | -92.0% | 7,157 | -93.4% | 0.00% | – |
Q2 2017 | $983,000 | +391.5% | 108,600 | +593.7% | 0.00% | – |
Q1 2017 | $200,000 | +239.0% | 15,656 | +149.9% | 0.00% | – |
Q4 2016 | $59,000 | +37.2% | 6,266 | +41.4% | 0.00% | – |
Q3 2016 | $43,000 | +975.0% | 4,431 | +748.9% | 0.00% | – |
Q2 2016 | $4,000 | +300.0% | 522 | +135.1% | 0.00% | – |
Q1 2016 | $1,000 | -85.7% | 222 | -57.1% | 0.00% | – |
Q4 2015 | $7,000 | -93.9% | 518 | -95.5% | 0.00% | – |
Q3 2015 | $115,000 | +721.4% | 11,591 | +2181.7% | 0.00% | – |
Q2 2015 | $14,000 | -79.4% | 508 | -77.6% | 0.00% | – |
Q1 2015 | $68,000 | +65.9% | 2,268 | +105.8% | 0.00% | – |
Q4 2014 | $41,000 | +156.2% | 1,102 | +134.5% | 0.00% | – |
Q3 2014 | $16,000 | +45.5% | 470 | +99.2% | 0.00% | – |
Q2 2014 | $11,000 | +22.2% | 236 | -21.6% | 0.00% | – |
Q1 2014 | $9,000 | +350.0% | 301 | +144.7% | 0.00% | – |
Q4 2013 | $2,000 | – | 123 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |